Evolution of 2-LTR episomal HIV-1 DNA in raltegravir-treated patients and in vitro-infected cells

被引：0
|
作者：
Reigadas, S. [1 ]
Andreola, M. L. [2 ]
Wittkop, L. [3 ]
Cosnefroy, O. [2 ]
Anies, G. [1 ]
Recordon-Pinson, P. [1 ]
Thiebaut, R. [3 ]
Masquelier, B. [1 ]
Fleury, H. [1 ]
机构：
[1] Univ Bordeaux 2, Virol Lab, EA2968, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, CNRS, UMR5234, Pathol Infect & Canc IFR66, F-33076 Bordeaux, France
[3] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France
来源：
ANTIVIRAL THERAPY | 2009年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
82
引用
收藏
页码：A97 / A97
页数：1
相关论文
共 50 条
  • [41] Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure
    Jose Ángel Fernández-Caballero
    Natalia Chueca
    Marta Álvarez
    María Dolores Mérida
    Josefa López
    José Antonio Sánchez
    David Vinuesa
    María Ángeles Martínez
    José Hernández
    Federico García
    BMC Infectious Diseases, 16
  • [42] Significant differences in DNA viral load between HIV-1 and HIV-2 infected patients
    Gueudin, Marie
    Benard, Antoine
    Chene, Genevieve
    Matheron, Sophie
    Simon, Francois
    AIDS, 2008, 22 (12) : 1519 - 1520
  • [43] QUANTITATION BY COMPETITIVE PCR OF HIV-1 PROVIRAL DNA IN EPIDERMAL LANGERHANS CELLS OF HIV-INFECTED PATIENTS
    CIMARELLI, A
    ZAMBRUNO, G
    MARCONI, A
    GIROLOMONI, G
    BERTAZZONI, U
    GIANNETTI, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (03): : 230 - 235
  • [44] Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure
    Angel Fernandez-Caballero, Jose
    Chueca, Natalia
    Alvarez, Marta
    Dolores Merida, Maria
    Lopez, Josefa
    Antonio Sanchez, Jose
    Vinuesa, David
    Angeles Martinez, Maria
    Hernandez, Jose
    Garcia, Federico
    BMC INFECTIOUS DISEASES, 2016, 16
  • [45] Visualization of HIV-1 RNA Transcription from Integrated HIV-1 DNA in Reactivated Latently Infected Cells
    Ukah, Obiaara B.
    Puray-Chavez, Maritza
    Tedbury, Philip R.
    Herschhorn, Alon
    Sodroski, Joseph G.
    Sarafianos, Stefan G.
    VIRUSES-BASEL, 2018, 10 (10):
  • [46] HIV-1/HIV-2 SERONEGATIVITY IN HIV-1 SUBTYPE-O INFECTED PATIENTS
    LOUSSERTAJAKA, I
    BRUNVEZINET, F
    SIMON, F
    LY, TD
    CHAIX, ML
    SARAGOSTI, S
    COUROUCE, AM
    INGRAND, D
    LANCET, 1994, 343 (8910): : 1393 - 1394
  • [47] DNA-SEQUENCES RESPONSIBLE FOR HIV-1 NEUROTROPISM IN INFECTED PATIENTS
    ROLFS, A
    WEBER, I
    NEUROLOGY, 1994, 44 (04) : A366 - A366
  • [48] CLINICAL CORRELATIONS IN HIV-1 AND HIV-2 INFECTED PATIENTS
    MONTEIROGOILLA, M
    SOUSA, AP
    GALVAO, J
    YUEH, M
    MARQUESNEVES, C
    RIBERODASILVA, J
    VISION RESEARCH, 1995, 35 : 3211 - 3211
  • [49] One-step nested PCR for detection of 2 LTR circles in PBMCs of HIV-1 infected patients with no detectable plasma HIV RNA
    Lusi, EA
    Guarascio, P
    Presutti, C
    Villani, R
    Pellicelli, A
    Soccorsi, F
    JOURNAL OF VIROLOGICAL METHODS, 2005, 125 (01) : 11 - 13
  • [50] Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA
    Gariglio, R
    Taborda, MA
    Bortolozzi, R
    McDermott, JL
    Martini, I
    Borgognone, M
    Villanova, GV
    Varnier, OE
    Giri, AA
    MEDICINA-BUENOS AIRES, 2004, 64 (05) : 419 - 428
12345